Filing Flows › TG Therapeutics (TGTX) › Recalls, complaints & regulation

TG Therapeutics (TGTX): clinical trials

TG Therapeutics (TGTX) beyond its filings: 12 active clinical trials.

TG Therapeutics' latest quarter

TG Therapeutics, Q2 2026: revenue $240M (+70% year over year), operating margin 9.0%, net earnings $7.8M, operating cash flow $39.3M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does TG Therapeutics have?

12 active studies on ClinicalTrials.gov, 4 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.